Stock Market Sleeps On Stereotaxis MAGiC CE Mark

Group 1 - The company Stereotaxis (NYSE: STXS) was initially expected to receive approval for its MAGiC technology in Europe by late 2022 and in the United States two years later, indicating a miscalculation in the timeline for regulatory approval [1] - Stereotaxis represents the largest investment position for the analyst, highlighting significant confidence in the company's potential [2]